The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Bexsero is indicated for active immunisation of individuals from 2 months of age and older against invasive meningococcal disease caused by Neisseria meningitidis group B. The impact of invasive disease in different age groups as well as the variability of antigen epidemiology for group B strains in different geographical areas should be considered when vaccinating. See Pharmacology: Pharmacodynamics under Actions for information on protection against specific group B strains. The use of this vaccine should be in accordance with official recommendations.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign Out
